Analystreport

Iovance Biotherapeutics Inc (NASDAQ: IOVA) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating.

Iovance Biotherapeutics, Inc.  (IOVA) 
Last iovance biotherapeutics, inc. earnings: 2/25 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: iovance.com